These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26414562)

  • 1. Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial.
    Petry TZ; Fabbrini E; Otoch JP; Carmona MA; Caravatto PP; Salles JE; Sarian T; Correa JL; Schiavon CA; Patterson BW; Cohen R; Klein S
    Obesity (Silver Spring); 2015 Oct; 23(10):1973-9. PubMed ID: 26414562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.
    Klein S; Fabbrini E; Patterson BW; Polonsky KS; Schiavon CA; Correa JL; Salles JE; Wajchenberg BL; Cohen R
    Obesity (Silver Spring); 2012 Jun; 20(6):1266-72. PubMed ID: 22262157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
    Jirapinyo P; Haas AV; Thompson CC
    Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.
    Cohen R; Caravatto PP; Correa JL; Noujaim P; Petry TZ; Salles JE; Schiavon CA
    Surg Obes Relat Dis; 2012; 8(4):375-80. PubMed ID: 22410638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
    de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
    Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus.
    Weng SG; Zhang B; Wang X; Chen H
    Obes Surg; 2017 Aug; 27(8):2067-2072. PubMed ID: 28233263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.
    Cohen R; le Roux CW; Papamargaritis D; Salles JE; Petry T; Correa JL; Pournaras DJ; Galvao Neto M; Martins B; Sakai P; Schiavon CA; Sorli C
    Diabet Med; 2013 Dec; 30(12):1482-6. PubMed ID: 23802863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.
    Geloneze B; Geloneze SR; Chaim E; Hirsch FF; Felici AC; Lambert G; Tambascia MA; Pareja JC
    Ann Surg; 2012 Jul; 256(1):72-8. PubMed ID: 22664560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
    Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
    J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.
    Rubino F; Marescaux J
    Ann Surg; 2004 Jan; 239(1):1-11. PubMed ID: 14685093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model.
    Hu C; Su Q; Li F; Zhang G; Sun D; Han H; Liu S; Hu S
    Obes Surg; 2014 Sep; 24(9):1453-62. PubMed ID: 24728905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.
    Han H; Wang L; Du H; Jiang J; Hu C; Zhang G; Liu S; Zhang X; Liu T; Hu S
    Obes Surg; 2015 Oct; 25(10):1802-9. PubMed ID: 25726319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifts in intestinal microbiota after duodenal exclusion favor glycemic control and weight loss: a randomized controlled trial.
    Cortez RV; Petry T; Caravatto P; Pessôa R; Sanabani SS; Martinez MB; Sarian T; Salles JE; Cohen R; Taddei CR
    Surg Obes Relat Dis; 2018 Nov; 14(11):1748-1754. PubMed ID: 30174193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.
    Kindel TL; Martins PJ; Yoder SM; Jandacek RJ; Seeley RJ; D'Alessio DA; Obici S; Tso P
    Obesity (Silver Spring); 2011 Feb; 19(2):380-7. PubMed ID: 21030948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes.
    Cohen RV; Neto MG; Correa JL; Sakai P; Martins B; Schiavon CA; Petry T; Salles JE; Mamedio C; Sorli C
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E279-82. PubMed ID: 23337729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain.
    Li N; Yan QT; Jing Q; Pan RY; Wang HJ; Jiang B; Li XJ; Wang Y; Dong JH; Wang XJ; Zhang MJ; Meng QG; Li XZ; Liu ZJ; Gao ZQ; Qu MH
    Obes Surg; 2020 Jan; 30(1):279-289. PubMed ID: 31605365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model.
    Hu C; Zhang G; Sun D; Han H; Hu S
    Obes Surg; 2013 Sep; 23(9):1436-44. PubMed ID: 23636998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.